IL108461A - History of ellipticine, their preparation and pharmaceutical preparations containing them - Google Patents

History of ellipticine, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL108461A
IL108461A IL10846194A IL10846194A IL108461A IL 108461 A IL108461 A IL 108461A IL 10846194 A IL10846194 A IL 10846194A IL 10846194 A IL10846194 A IL 10846194A IL 108461 A IL108461 A IL 108461A
Authority
IL
Israel
Prior art keywords
group
protected
substituted
unprotected
lower alkoxy
Prior art date
Application number
IL10846194A
Other languages
English (en)
Hebrew (he)
Other versions
IL108461A0 (en
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of IL108461A0 publication Critical patent/IL108461A0/xx
Publication of IL108461A publication Critical patent/IL108461A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL10846194A 1993-01-29 1994-01-28 History of ellipticine, their preparation and pharmaceutical preparations containing them IL108461A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1344193 1993-01-29

Publications (2)

Publication Number Publication Date
IL108461A0 IL108461A0 (en) 1994-04-12
IL108461A true IL108461A (en) 1998-09-24

Family

ID=11833224

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10846194A IL108461A (en) 1993-01-29 1994-01-28 History of ellipticine, their preparation and pharmaceutical preparations containing them

Country Status (11)

Country Link
US (2) US5565569A (fr)
EP (1) EP0608876A1 (fr)
KR (1) KR940018385A (fr)
CN (1) CN1042731C (fr)
AU (1) AU666416B2 (fr)
CA (1) CA2114468A1 (fr)
FI (1) FI940403A (fr)
IL (1) IL108461A (fr)
MY (1) MY110683A (fr)
SG (1) SG42916A1 (fr)
TW (1) TW269688B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696465B1 (fr) * 1992-10-02 1994-12-23 Adir Nouveaux dérivés d'ellipticine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2757859B1 (fr) * 1996-12-30 1999-01-29 Adir Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2757858B1 (fr) * 1996-12-30 1999-01-29 Adir Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6512102B1 (en) * 1998-12-31 2003-01-28 Chiron Corporation Compositions and methods of diagnosis and treatment using casein kinase I
EP2468277A1 (fr) * 2002-05-31 2012-06-27 Pharmagenesis, Inc. Dérivés de la triptolide pour la modulation de l'apoptose et l'immunosuppression
EP1877098B1 (fr) * 2005-05-05 2013-04-24 Chroma Therapeutics Limited Conjugués d'un ester d'aminoacide alpha et d'un médicament hydrolysables par la carboxylestérase
FR2925491B1 (fr) * 2007-12-19 2010-09-03 Oz Biosciences Sas Nouvelle classe de lipides cationiques pour le transport d'agents actifs dans les cellules
US20150119388A1 (en) * 2012-06-15 2015-04-30 The Children's Hospital Philadelphia Novel pro- and codrug derivatives for nanoparticle delivery of select anticancer agents formed using rapidly cleavable phenolic ester bridges

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933827A (en) * 1974-10-29 1976-01-20 Hoffmann-La Roche Inc. 9-Acyloxy-5,11-dimethyl-6H-pyrido[4,3-B]carbazoles
FR2308365A2 (fr) * 1975-04-25 1976-11-19 Anvar Derives de l'hydroxy-9 ellipticine et leur application therapeutique
US4310667A (en) * 1976-04-22 1982-01-12 Agence Nationale De Valorisation De La Recherche (Anvar) 2-N Quaternary ammonium salt derivatives of 9-hydroxy ellipticine
JPS6137799A (ja) * 1984-07-31 1986-02-22 Suntory Ltd エリプチシン誘導体およびその製造法
AU4245689A (en) * 1988-10-04 1990-04-12 Suntory Limited Ellipticine glycoside derivatives
JPH05310736A (ja) * 1992-05-06 1993-11-22 Tanabe Seiyaku Co Ltd エリプティシン誘導体、その製法およびその合成中間体
FR2696465B1 (fr) * 1992-10-02 1994-12-23 Adir Nouveaux dérivés d'ellipticine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5272146A (en) * 1992-10-02 1993-12-21 The United States Of America As Represented By The United States Department Of Health And Human Services 1,2-dihydroellipticines with activity against CNS specific cancer cell lines

Also Published As

Publication number Publication date
EP0608876A1 (fr) 1994-08-03
TW269688B (fr) 1996-02-01
MY110683A (en) 1999-01-30
FI940403A (fi) 1994-07-30
CN1042731C (zh) 1999-03-31
AU666416B2 (en) 1996-02-08
US5565569A (en) 1996-10-15
KR940018385A (ko) 1994-08-16
CN1099034A (zh) 1995-02-22
SG42916A1 (en) 1997-10-17
IL108461A0 (en) 1994-04-12
US5605904A (en) 1997-02-25
CA2114468A1 (fr) 1994-07-30
FI940403A0 (fi) 1994-01-27
AU5394794A (en) 1994-08-04

Similar Documents

Publication Publication Date Title
EP0354583B1 (fr) Dérivés du DC-88A
WO2018226801A1 (fr) Dérivés d'aryldiazépine utilisés en tant qu'inhibiteurs du vrs
CA2192824C (fr) Derives de l'acide pyridone-carboxylique, procedes de preparation connexe et agents anti-tumorals contenant ces derives
KR19980703203A (ko) 신규 펩티드 유도체
IL108461A (en) History of ellipticine, their preparation and pharmaceutical preparations containing them
CA2076982A1 (fr) Derives d'acide pyridonecarboxylique
AU2005221959C1 (en) Novel indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug each comprising the same
US4833145A (en) 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives
CN110357905B (zh) 作为蛋白激酶抑制剂的大环类衍生物及其制备方法和用途
CA1301156C (fr) Derives de la 4(3h)-oxo-4,6,7,8,-tetrahydropyrido[2,3-d] pyrimidine
JPH0892090A (ja) 医薬組成物
WO1997046551A1 (fr) Analogues de quinolylmethylen-oxindole substitues en tant qu'inhibiteurs des tyrosines kinases
JPS61100564A (ja) ペプチドで置換された複素環免疫促進剤
JP3163391B2 (ja) スチルベン誘導体及びそれを含有する制癌剤
AU1278392A (en) N-(alpha-substituted-pyridinyl)carbonyl dipeptide antihypertensive agents
EP0266896B1 (fr) 7-(Phénylglycine(substituée sur la position meta))-1-carba-1-déthiacéphalosporines
JP2820881B2 (ja) エリプティシン誘導体およびその製法
AU704115B2 (en) Zwitterionic forms of trovafloxacin
JP7434273B2 (ja) アゼチジン誘導体のボレート
US20040067959A1 (en) Morphinoid derivatives as delta-opioid agonists and antagonists
Napoleon et al. Novel synthesis of process related impurities of valganciclovir hydrochloride
JPH05194517A (ja) ６−メルカプトプリン誘導体及びその製法
CA1259318A (fr) Preparation de derives de substitution en 2-azetidinone; medicaments renfermant ces derives
EP0847400A1 (fr) Polymorphes du promedicament 6-n-(l-ala-l-ala)-trovafloxacine
CA1326848C (fr) Derives uridine substitues en 5 et intermediaires pour leur preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void